From April 1, 2024 to June 30, 2024, the company has repurchased 1,354,900 shares, representing 1.73% for CNY 32.11 million. With this, the company has completed the repurchase of 4,036,458 shares, representing 5.05% for CNY 93.42 million under the buyback announced on February 29, 2024.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
Equities
301130
CNE1000058C4
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.1 CNY | -0.04% | -0.26% | -17.14% |
1st Jan change | Capi. | |
---|---|---|
-17.14% | 249M | |
+62.78% | 856B | |
+38.95% | 631B | |
-4.01% | 359B | |
+16.00% | 325B | |
+8.90% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.47% | 177B | |
+1.89% | 165B |
- Stock Market
- Equities
- 301130 Stock
- News Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
- Tranche Update on Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd's Equity Buyback Plan announced on February 29, 2024.